Vasileios-Arsenios Lioutas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 26 | 2024 | 2660 | 3.890 |
Why?
|
Stroke | 30 | 2023 | 9962 | 2.210 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2024 | 892 | 1.570 |
Why?
|
Brain Ischemia | 11 | 2020 | 3127 | 1.240 |
Why?
|
Siderosis | 2 | 2020 | 103 | 1.170 |
Why?
|
Anticoagulants | 7 | 2024 | 4897 | 1.130 |
Why?
|
Vitamin K | 5 | 2019 | 321 | 0.870 |
Why?
|
Neurology | 2 | 2022 | 779 | 0.870 |
Why?
|
Headache Disorders, Primary | 1 | 2022 | 39 | 0.820 |
Why?
|
Vasospasm, Intracranial | 2 | 2022 | 215 | 0.810 |
Why?
|
Tissue Plasminogen Activator | 5 | 2022 | 1190 | 0.790 |
Why?
|
Neuroprotective Agents | 2 | 2019 | 961 | 0.710 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2023 | 385 | 0.690 |
Why?
|
Insulin | 7 | 2023 | 6597 | 0.680 |
Why?
|
CADASIL | 1 | 2020 | 88 | 0.660 |
Why?
|
Magnesium Sulfate | 1 | 2019 | 73 | 0.640 |
Why?
|
Intracranial Hemorrhages | 3 | 2021 | 844 | 0.590 |
Why?
|
Hyperglycemia | 2 | 2023 | 1380 | 0.570 |
Why?
|
Hematoma | 2 | 2018 | 769 | 0.560 |
Why?
|
Ischemic Attack, Transient | 2 | 2021 | 901 | 0.530 |
Why?
|
Off-Label Use | 1 | 2017 | 184 | 0.520 |
Why?
|
Cerebrovascular Disorders | 1 | 2022 | 1501 | 0.510 |
Why?
|
Foramen Ovale, Patent | 1 | 2018 | 214 | 0.500 |
Why?
|
Vertebrobasilar Insufficiency | 2 | 2014 | 112 | 0.490 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36290 | 0.460 |
Why?
|
Brain Edema | 3 | 2023 | 603 | 0.460 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 640 | 0.440 |
Why?
|
Hypoglycemic Agents | 5 | 2022 | 3150 | 0.420 |
Why?
|
Thrombectomy | 5 | 2021 | 708 | 0.420 |
Why?
|
Thrombolytic Therapy | 6 | 2022 | 2108 | 0.410 |
Why?
|
Administration, Intranasal | 5 | 2022 | 471 | 0.370 |
Why?
|
Amblyopia | 1 | 2013 | 150 | 0.360 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2696 | 0.360 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1328 | 0.350 |
Why?
|
Muscle Weakness | 1 | 2012 | 413 | 0.330 |
Why?
|
Humans | 71 | 2024 | 760621 | 0.320 |
Why?
|
Ischemia | 1 | 2017 | 1893 | 0.320 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58995 | 0.320 |
Why?
|
Biomedical Research | 1 | 2024 | 3426 | 0.310 |
Why?
|
Hypertension | 3 | 2023 | 8594 | 0.310 |
Why?
|
Aged | 31 | 2024 | 169152 | 0.290 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2015 | 1928 | 0.290 |
Why?
|
Hospital Mortality | 2 | 2018 | 5425 | 0.280 |
Why?
|
Tobacco Use Disorder | 1 | 2013 | 700 | 0.280 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15840 | 0.280 |
Why?
|
Respiration, Artificial | 1 | 2018 | 2622 | 0.280 |
Why?
|
Retrospective Studies | 14 | 2023 | 80372 | 0.250 |
Why?
|
Male | 36 | 2024 | 359744 | 0.250 |
Why?
|
Administration, Oral | 5 | 2019 | 4035 | 0.250 |
Why?
|
Medicare | 1 | 2023 | 6786 | 0.250 |
Why?
|
Fibrinolytic Agents | 6 | 2022 | 2167 | 0.250 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5889 | 0.240 |
Why?
|
Deferoxamine | 2 | 2022 | 153 | 0.240 |
Why?
|
Cohort Studies | 9 | 2023 | 41335 | 0.240 |
Why?
|
Female | 38 | 2024 | 391270 | 0.240 |
Why?
|
Edema | 3 | 2023 | 769 | 0.240 |
Why?
|
Middle Aged | 29 | 2024 | 220352 | 0.230 |
Why?
|
Brain | 7 | 2023 | 26951 | 0.210 |
Why?
|
Alcoholism | 1 | 2013 | 1961 | 0.200 |
Why?
|
Risk Assessment | 3 | 2021 | 24123 | 0.200 |
Why?
|
Gross Domestic Product | 1 | 2022 | 78 | 0.200 |
Why?
|
Treatment Outcome | 13 | 2023 | 65017 | 0.180 |
Why?
|
Fibrinolysis | 1 | 2022 | 332 | 0.180 |
Why?
|
Organizational Culture | 1 | 2024 | 506 | 0.180 |
Why?
|
Prospective Studies | 11 | 2023 | 54303 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 12293 | 0.180 |
Why?
|
Hyperemia | 1 | 2021 | 221 | 0.170 |
Why?
|
Vasoconstriction | 1 | 2022 | 593 | 0.170 |
Why?
|
Risk Factors | 9 | 2023 | 74359 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3334 | 0.160 |
Why?
|
Recovery of Function | 2 | 2020 | 2985 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 518 | 0.140 |
Why?
|
Bystander Effect | 1 | 2017 | 90 | 0.140 |
Why?
|
Headache | 2 | 2022 | 1249 | 0.140 |
Why?
|
Pituitary Apoplexy | 1 | 2016 | 29 | 0.140 |
Why?
|
Workload | 1 | 2022 | 847 | 0.140 |
Why?
|
Prognosis | 7 | 2023 | 29658 | 0.130 |
Why?
|
Alzheimer Disease | 1 | 2018 | 8547 | 0.130 |
Why?
|
Dysarthria | 1 | 2016 | 58 | 0.130 |
Why?
|
Deglutition Disorders | 1 | 2022 | 626 | 0.130 |
Why?
|
Arteries | 1 | 2021 | 1126 | 0.130 |
Why?
|
Blood Pressure | 3 | 2023 | 8525 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1677 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2020 | 10344 | 0.130 |
Why?
|
Hydrocephalus | 1 | 2022 | 763 | 0.130 |
Why?
|
Intracranial Hypotension | 1 | 2015 | 40 | 0.120 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2018 | 278 | 0.120 |
Why?
|
Middle Cerebral Artery | 1 | 2016 | 276 | 0.120 |
Why?
|
Incidence | 3 | 2023 | 21392 | 0.120 |
Why?
|
Internationality | 1 | 2019 | 1004 | 0.110 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2016 | 281 | 0.110 |
Why?
|
Disease Progression | 3 | 2020 | 13502 | 0.110 |
Why?
|
Basilar Artery | 1 | 2014 | 205 | 0.110 |
Why?
|
Vertebral Artery | 1 | 2014 | 185 | 0.110 |
Why?
|
Intracranial Pressure | 1 | 2016 | 325 | 0.110 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 249 | 0.110 |
Why?
|
Intracranial Hypertension | 1 | 2016 | 193 | 0.110 |
Why?
|
Sodium Chloride | 1 | 2015 | 591 | 0.110 |
Why?
|
Diffusion Tensor Imaging | 3 | 2023 | 2385 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14495 | 0.100 |
Why?
|
Magnetic Field Therapy | 1 | 2012 | 27 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2020 | 22053 | 0.100 |
Why?
|
Hospitalization | 3 | 2021 | 10790 | 0.100 |
Why?
|
Brain Injuries | 1 | 2023 | 2044 | 0.100 |
Why?
|
Glucose | 1 | 2023 | 4351 | 0.100 |
Why?
|
Patient Transfer | 1 | 2018 | 779 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2015 | 749 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1386 | 0.090 |
Why?
|
Upper Extremity | 1 | 2015 | 661 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3113 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8624 | 0.090 |
Why?
|
Memory | 1 | 2020 | 2179 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2016 | 686 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1518 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25942 | 0.080 |
Why?
|
Cerebrovascular Circulation | 2 | 2018 | 2733 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2782 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3568 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3213 | 0.080 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2016 | 1032 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1313 | 0.070 |
Why?
|
Double-Blind Method | 4 | 2023 | 12427 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 12965 | 0.070 |
Why?
|
Adult | 9 | 2023 | 219994 | 0.070 |
Why?
|
Stress, Psychological | 1 | 2022 | 4446 | 0.070 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1274 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2754 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3455 | 0.060 |
Why?
|
Databases, Factual | 2 | 2023 | 8035 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9280 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12808 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20509 | 0.060 |
Why?
|
Massachusetts | 1 | 2016 | 8803 | 0.060 |
Why?
|
Drainage | 2 | 2022 | 1161 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3976 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40165 | 0.050 |
Why?
|
Sex Factors | 1 | 2016 | 10547 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4048 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15687 | 0.050 |
Why?
|
Medical Futility | 1 | 2022 | 133 | 0.050 |
Why?
|
United States | 3 | 2023 | 72461 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2014 | 2165 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11891 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18416 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42063 | 0.040 |
Why?
|
Collateral Circulation | 1 | 2018 | 292 | 0.040 |
Why?
|
Water | 1 | 2023 | 1407 | 0.040 |
Why?
|
Acute Disease | 2 | 2020 | 7269 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.040 |
Why?
|
Blood Glucose | 2 | 2022 | 6381 | 0.030 |
Why?
|
Eating | 1 | 2023 | 1539 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18137 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15757 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2020 | 982 | 0.030 |
Why?
|
Injections, Spinal | 1 | 2015 | 316 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1722 | 0.030 |
Why?
|
Plasminogen Activators | 1 | 2014 | 199 | 0.030 |
Why?
|
Radial Artery | 1 | 2016 | 196 | 0.030 |
Why?
|
Women's Health | 1 | 2023 | 2056 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.030 |
Why?
|
Pyramidal Tracts | 1 | 2015 | 250 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2014 | 172 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2419 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39261 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 2016 | 542 | 0.030 |
Why?
|
Anisotropy | 1 | 2016 | 1278 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2018 | 1996 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2852 | 0.030 |
Why?
|
Child | 1 | 2020 | 79806 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 87810 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2019 | 888 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2016 | 1377 | 0.020 |
Why?
|
Cognition | 2 | 2020 | 6957 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1738 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9716 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
Vision Disorders | 1 | 2016 | 1084 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4433 | 0.020 |
Why?
|
Fever | 1 | 2016 | 1617 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2020 | 1925 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2618 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2916 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1784 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3505 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8469 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3758 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6180 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7021 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6965 | 0.010 |
Why?
|
Animals | 1 | 2015 | 167963 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15289 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29749 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9287 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8950 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12626 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5209 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15789 | 0.010 |
Why?
|
Heart Failure | 1 | 2021 | 11847 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17790 | 0.010 |
Why?
|